Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TMEM95 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SSMEM1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC16A11 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ADAMTS19 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TLR2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MYOM3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
MAP3K2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ISM2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
LMOD3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ND4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
INO80D - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TPH1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC105376100 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SKAP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZAR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LRRTM1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FSHR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
APOPT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on